Want to join the conversation?
Goldman, Sachs & Co. analyst Taposh Bari probes on the expense structure. $BID CFO Michael Goss says that the total change period-to-period on a reported basis on comp expense is $5.2MM, up 8%. Out of this, taking out $4.3MM of expenses, $BID's compensation expense is down 7% period-to-period, due to improvements made in pension obligations in UK.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?